Illumina inks a long-term NGS deal with Dutch company Qiagen
  Author: Pankaj Singh

The pharmaceutical industry is responsible for treating some of the most critical health issues. The sector produces, ...

Read More
HMS invests $7.5Mn in digital medication management firm MedAdvisor
  Author: Paroma Bhattacharya

Medication adherence or taking medications correctly and on time is one of the most important parts of any treatment. ...

Read More
Graybug Vision commences Phase 2b Clinical study to target wet AMD
  Author: Pankaj Singh

Macular degeneration is the leading cause of irreversible, serious vision loss that occurs when a section of...

Read More
Servier buys PIXUVRI Non-Hodgkin lymphoma therapy from CTI BioPharma
  Author: Saipriya Iyer

A substantial rise in occurrence of cancer cases is being witnessed across the globe lately. Various global pharmaceutical firms are increasingly w...

Read More
Merck reveals positive results from KEYTRUDA® Plus Phase 3 trial
  Author: Pankaj Singh

Breast cancer is initiated when genes regulating cell growth mutate. These mutations allows the cells to divide and mu...

Read More
Treos Bio updates results of phase 1/2 trial of its cancer vaccine
  Author: Paroma Bhattacharya

Vaccine-specific T cell responses were initially anticipated by PEPI test (via the complete HLA genotype of pa...

Read More
Mustang Bio reveals Phase 1 Trial Of MB-105 For Prostate Cancer
  Author: Saipriya Iyer

Prostate cancer (medically referred as prostatic carcinoma) is a type of cancer that is mostly found among m...

Read More
Exact Sciences Cologuard® test gets label expansion approval from FDA
  Author: Paroma Bhattacharya

Colorectal cancer cases are increasingly growing across the world, however it is one of those cancers which can be tre...

Read More
Celltrion’s CT-P13 gets CHMP positive opinion for Rheumatoid Arthritis
  Author: Saipriya Iyer

Rheumatoid Arthritis is a progressive, long-term and a disabling autoimmune disease. Rheumatoid Arthritis affects more...

Read More
XORTX reveals positive results for Phase 2 trial of TMX-049
  Author: Pankaj Singh

Type 2 diabetes is a prevailing disease in which cells become unresponsive to insulin while gradually increasing blood...

Read More
Poxel releases detailed Imeglimin Phase 3 results from TIMES 1 program
  Author: Paroma Bhattacharya

Type 2 diabetes is a prevailing disease in which cells become unresponsive to insulin while gradually increasing blood...

Read More
Poxel commences its Phase 1b trial for NASH drug candidate, PXL065
  Author: Paroma Bhattacharya

Nonalcoholic steatohepatitis (NASH) is liver inflammation caused by the buildup of fat in the liver mostly with people...

Read More
Emergency Care Partners finalizes its merger with Chicago’s IEMS
  Author: Pankaj Singh

With rising cases of roadside accidents worldwide, the need for emergency medical facilities have increased considerab...

Read More
Zelegent expands to OSA therapeutics with MISH platform acquisition
  Author: Pankaj Singh

MISH Technology stands for Minimally Invasive Suspension of the Hyoid and is a novel pre-clinical produ...

Read More
Google to open new office in Rochester under Mayo Clinic partnership
  Author: Saipriya Iyer

This new Google collaboration would involve records such as videos, some reports as well as scans that ...

Read More
4BIO Capital intends to take gene and cell therapies mainstream
  Author: Paroma Bhattacharya

The venture capitalist firm has secured an investment of $50 million and is expecting to gather an investment ...

Read More
Lung Ambition Alliance reveals plans to double lung cancer survival
  Author: Paroma Bhattacharya

New program will be launched to help local initiatives run by patient organizations that contain the ca...

Read More
SunGen Pharma and Elite Pharmaceuticals file an ANDA with the FDA
  Author: Pankaj Singh

This is the second ANDA filed by both the companies, giving Elite Pharmaceutical the exclusive right to retail...

Read More
Ribon Therapeutics doses first patient in RBN-2397 Phase 1 trial
  Author: Pankaj Singh

The Phase 1 clinical trial assessing RBN-2397 will be the first clinical evaluation of monoPARP Inhibit...

Read More
Vertex acquires Semma Therapeutics for $950M to develop diabetes cure
  Author: Paroma Bhattacharya

The acquisition for $950 million has been an all-cash deal.   ...

Read More
Aridis Pharmaceuticals announces results from clinical trial of AR-105
  Author: Saipriya Iyer

Aridis Pharmaceuticals, Inc., a U.S.-based biopharmaceutical company focused on developing innovative anti-infective t...

Read More
Inotrem nangibotide program gets Fast Track designation from the FDA
  Author: Pankaj Singh

The company’s therapeutic solution is capable of being the first septic shock treatment which is mechanism-based. ...

Read More
Immunicum AB reveals positive Phase II MERECA clinical trial data
  Author: Paroma Bhattacharya

Satisfactory safety profile and the positive number of complete responses by the trials firmly justify the pro...

Read More
Regenxbio to present interim update of RGX-314 Phase I/IIA trial
  Author: Pankaj Singh

Dr. Jeffery Heier, the primary investigator of the trial, will present the data during the Retina Subsp...

Read More
Enrollment concluded early in PCS-499 clinical trial for NL treatment
  Author: Paroma Bhattacharya

Clinical stage biopharmaceutical firm Processa Pharmaceuticals Inc today announced the last patient to be enrolled in ...

Read More
Lupins Pharma Dynamics signs distribution agreement with Creso Pharma
  Author: Pankaj Singh

The deal gives Lupin access to Creso’s cannaQIX product range, which are nutraceuticals based on ...

Read More
Altaire’s veterinary ophthalmic products recalled due to QA concerns
  Author: Sunil Hebbalkar

Altaire Pharmaceuticals recalls specific product/lots of ophthalmic drugs created for Dechra Veterinary Products, due to sterility c...

Read More
Mundipharma submits license extension for Invokana & Vokanamet to EMA
  Author: Pankaj Singh

CREDENCE renal outcome study, that was stopped early because of positive efficacy findings, laid the fo...

Read More
Outlook Therapeutics finishes patient registration for NORSE 1 trial
  Author: Paroma Bhattacharya

NORSE 1 has registered a sum of 61 patients from nine different sites in Australia. &nb...

Read More
Biogen & Invitae introduce SMA STAT test for faster genetic testing
  Author: Sunil Hebbalkar

Global biotechnology expert Biogen Inc. and advanced genetics leader Invitae Corporation have reportedly announced the...

Read More
FDA approves Rozlytrek™ for cancer patients with ROS1-positive & NTRK
  Author: Sunil Hebbalkar

FDA approves Rozlytrek™ for cancer patients with ROS1-positive & NTRK ...

Read More
Bio-Thera Solutions commences Phase 1 study for Simponi® biosimilar
  Author: Paroma Bhattacharya

Bio-Thera Solutions, a China based pharmaceutical company, has reportedly announced the start of dosing of its first b...

Read More
Mevion & C-RAD integrate for better treatment in proton therapy
  Author: Paroma Bhattacharya

C-RAD to offer a specific version of Catalyst System named Catalyst PT in proton therapy....

Read More
Experian takes over MyHealthDirect for patient engagement and access
  Author: Pankaj Singh

MyHealthDirect’s easy-to-understand technology guides its patients to profound and right care....

Read More
Astrazenca reveals positive results from Phase III trial of Lynparza
  Author: Paroma Bhattacharya

Lynparza is a PARP inhibitor with promising Phase III results in ovarian breast pancreatic and prostate cancer...

Read More
Moderna doses first patients across four new Phase I clinical studies
  Author: Paroma Bhattacharya

Moderna, a biotech company that focuses on discovery and development of drugs and is based in Cambridge, Massachusetts...

Read More
Meiji Pharma launches two Santen ophthalmic products in Indonesia
  Author: Paroma Bhattacharya

Reports confirm that Meiji Seika Pharma Co., Ltd. (Meiji), a Japanese company, has recently announced the launch of tw...

Read More
Verona Pharma declares positive Phase 2 data of ensifentrine in COPD
  Author: Sunil Hebbalkar

The company announces positive results of ensifentrine for the treatment of chronic obstructive pulmona...

Read More
Telix Pharmaceuticals & DKFZ partner for image-guided prostate surgery
  Author: Paroma Bhattacharya

· Telix would work with DKFZ for required translational research to evaluate technology in surgical set...

Read More
Aleafia Health completes biggest order of adult-use cannabis till date
  Author: Sunil Hebbalkar

More than 13,000 cannabis plants are currently being cultivated at Port Perry Outdoor Facility, which a...

Read More
hVIVO confirms phase 1 trial of AGS-v PLUS for mosquito-borne diseases
  Author: Pankaj Singh

This clinical study will assess the safety and immunogenicity of vaccine when given with or without adjuvant t...

Read More
CTAS & ADA merge to support diabetic patients in the workplace
  Author: Sunil Hebbalkar

The union aims to develop ADA’s mission to cure diabetes and improve the lives of the people affe...

Read More
MediciNova gains approval to present abstract on ALS therapy MN-166
  Author: Paroma Bhattacharya

The company CMO, Kazuko Matsuda will present the abstract titled “Interaction (nonuniformity) of ALS Pro...

Read More
Herbalife Nutrition unveils a new product for athletes’ daily workout
  Author: Paroma Bhattacharya

The company launches Herbalife24 Branched-Chain Amino Acids powder to enhance athletes’ routine w...

Read More
Aino Health inks deal with 55BirchStreet to expand in German markets
  Author: Paroma Bhattacharya

Reports confirm that Sweden’s Aino Health and 55BirchStreet, a Germany-based digital consulting firm, have recen...

Read More
Aptose commences dosing first CLL patient in phase 1 study of CG-806
  Author: Pankaj Singh

Initial data from the first two cohorts has demonstrated MYC inhibition in patients with acute myelodysplastic...

Read More
NIH and partners to start HIV vaccine trial in Europe and America
  Author: Sunil Hebbalkar

A unit of Janssen Pharmaceutical Companies of Johnson & Johnson would be sponsoring the Mosaico tri...

Read More
Altimmune inks deal to acquire Spitfire Pharma and its NASH candidate
  Author: Saif Ali Bepari

Altimmune, Inc., a clinical stage biopharma company, has recently confirmed the closing of a formerly announced acquis...

Read More
Sun Pharma launches lipid disorders drug Ezallor Sprinkle™ in the U.S.
  Author: Pankaj Singh

Ezallor Sprinkle™ (rosuvastatin) capsules can be indicated for three lipid disorders in conjunction with...

Read More
MacroGenics, I-Mab team up to develop & market enoblituzumab in China
  Author: Paroma Bhattacharya

MacroGenics, Inc. and I-Mab Biopharma, a U.S. and China based clinical-stage biopharmaceutical company that is committed...

Read More
ViiV Healthcare announces positive result in TANGO Phase 3 study
  Author: Paroma Bhattacharya

ViiV Healthcare Limited, a pharmaceutical company specializing in HIV treatment, recently announced positive results f...

Read More
Compass Therapeutics announces first-in-human Phase 1 trial of CTX-471
  Author: Saipriya Iyer

CTX-471 has shown promising preclinical data, which include total eradication of established tumors in syngene...

Read More
Skyhawk Therapeutics expands licensing partnership with Biogen
  Author: Paroma Bhattacharya

Skyhawk Therapeutics, Inc. has recently announced the expansion of its partnership with Biogen, which was initially announced on January 4, 2019....

Read More
Priority review granted to BeiGene’s Tislelizumab in China by NMPA
  Author: Paroma Bhattacharya

BeiGene, Co., Ltd., a commercial-stage biotechnology company recently announced that China NMPA (National Medical Prod...

Read More
CARMAT unveils interim data on autoregulation from PIVOTAL trial
  Author: Paroma Bhattacharya

France-based CARMAT, the developer of the most advanced total artificial heart in the world aimed at offering therapeu...

Read More
PathogenDx, Zef Scientific partner to offer microbial testing platform
  Author: Paroma Bhattacharya

The propriety technology offered by PathogenDx will set a new standard in Canada for testing bacteria...

Read More
Neuralstem announces publication of phase 1 trial results of NSI-566
  Author: Paroma Bhattacharya

Subjects were provided immunosuppressive drugs for 28 days after transplantation and were observed for up to 2...

Read More
U.S. FDA approves Alembic Pharma’s Clonazepam tablets to treat seizure
  Author: Paroma Bhattacharya

Alembic Pharmaceuticals, an Indian multinational drug manufacturing company, recently announced that the U.S. Food and...

Read More
PHC Holdings buys Thermo Fisher’s anatomical pathology division
  Author: Paroma Bhattacharya

PHC Holdings Corporation, a global innovator in healthcare solutions, has reportedly concluded its acquisition of Ther...

Read More
VIVUS, Nordmark revise contract agreement for PANCREAZE development
  Author: Paroma Bhattacharya

California-headquartered biopharmaceutical firm VIVUS Inc. has recently announced an amendment to its contract manufac...

Read More
Zealand Pharma carries out Phase 1 clinical trial for SBS treatment
  Author: Paroma Bhattacharya

ZP7570 may be regarded as the next gen in the treatment and will help the SBS patients worldwide to unders...

Read More
PhaseBio reveals Phase 2a study results for PB2452 in older patients
  Author: Paroma Bhattacharya

The new data is consistent with the formally published Phase 1 trial data of younger subjects treated with tic...

Read More
Silk Road unveils results from ROADSTER-2 study of transcarotid stent
  Author: Paroma Bhattacharya

Silk Road Medical, Inc., a medical device company focused on reducing the risk of stroke and its harmful impact, has r...

Read More
Adverum Biotechnologies doses first Wet AMD patient in phase-1 trial
  Author: Pankaj Singh

The California-based Adverum Biotechnologies Inc., which caters to the unmet medical requirements in rare and ocular d...

Read More
Anthem acquires Beacon Health to expand behavioral health services
  Author: Paroma Bhattacharya

Anthem Inc, an American health insurance company, has recently announced that it has entered into a definitive agreeme...

Read More
NeurologyLive expands SAP program by partnering with Cleveland Clinic
  Author: Saif Ali Bepari

NeurologyLive has reportedly added the Cleveland Clinic to its Strategic Alliance Partnership (SAP) program. Michael J...

Read More
Bavarian Nordic unveils key Phase 2 study results for BN-Brachyur
  Author: Paroma Bhattacharya

Phase 2 trial was designed with the aim to observe combination of BN-Brachyury and radiation therapy in chordoma patie...

Read More
Celgene presents results of Iberdomide-Dexamethasone combination study
  Author: Pankaj Singh

Celgene Corporation, a U.S.-based biotechnology company recently announced first clinical results evaluating CC-220 (I...

Read More
Sihuan Pharma wins approval for Phase I to III trial of EGFR inhibitor
  Author: Paroma Bhattacharya

Sihuan Pharmaceutical Holdings Group, a leading cardio-cerebral vascular drug maker in prescription drug industry of C...

Read More
Myokardia reports positive results from clinical trial of MYK-491
  Author: Pankaj Singh

Myokardia, a clinical-stage biopharmaceutical company recently presented positive results from its phase 1a clinical tr...

Read More
Glenmark Pharma receives final approval for antiplatelet drug by USFDA
  Author: Paroma Bhattacharya

Glenmark Pharmaceuticals, a U.S.-based pharmaceutical company, recently announced that it has received a final approva...

Read More
Novartis’ asthma candidate beats GlaxoSmithKline’s in Phase 2 trial
  Author: Sunil Hebbalkar

The clinical study linked Novartis’ QVM149 to significant lung function improvements....

Read More
FDA and IBT seemingly in agreement on Phase III study design
  Author: Paroma Bhattacharya

The US Food and Drug Administration (FDA) has reportedly informed Infant Bacterial Therapeutics (IBT) in writing that ...

Read More
Masimo announces expanded partnership with Shenzhen Mindray for SET®
  Author: Paroma Bhattacharya

With the invention of Signal Extraction Technology® (SET®), Masimo has esta...

Read More
Medtronic unveils results from first-in-human study for EV ICD systems
  Author: Saipriya Iyer

Medtronic plc has reportedly unveiled the results from a test study of its investigational extravascular ICD system, w...

Read More